DCI Blog


Duke Cancer Institute (DCI) Blog provides updates, organizational announcements, the latest in funding opportunities and information on upcoming conferences and symposiums. This blog also highlights inspiring patient stories and the accomplishments and achievements of DCI faculty and staff. Subscribers are invited to submit story ideas and other news of interest. Email submissions and feedback to Karen E. Butler, Director of Communications, Duke Cancer Institute.

Supportive Care And Survivorship Day

The cancer journey is challenging at best. Consultations with multiple oncology specialists, surgeries, infusions and radiation are just par for the course. With so much focus on the disease, a day of rejuvenation is just what the doctor ordered. “Our patients are our heroes,” said Steve Patierno,...

Four-Year-Old Rings In A New Start

For more than 4,000 years, bells have been used to spread warnings, alerts and good tidings. Over the years, bells have even developed into sophisticated, melodious instruments. But for four-year-old Vanessa Burnette and her mother, Laura, the unpretentious clang, clang, clang of a rudimentary bell...

Lassiter Recognized At 40th Anniversary Congress

At its 40th Anniversary Congress last month the Oncology Nursing Society (ONS) presented the Excellence in Blood and Marrow Transplantation Award to Martha E. Lassiter, RN, MSN, AOCNS, BMTCN, clinical nurse specialist, Duke Adult Bone Marrow Transplant Program. “This is an award for our entire...

Godfrey Joins Duke Cancer Center OTC

Emily Godfrey, PA-C, recently joined the Oncology Treatment Center at Duke. In her new role she will oversee the care of patients experiencing complications resulting from cancer and cancer therapies, such as nausea, febrile neutropenia, pain, fatigue, depression and hypersensitivity reactions. “...

ACA Policies and Out-of-Pocket Caps

A hypothetical leukemia patient buying the life-extending drug therapy for his condition would reach his annual out-of-pocket maximum in a month on most of the bronze policies and half of the silver policies offered through the Affordable Care Act marketplace. The findings, reported by researchers...

Scientists Block Breast Cancer Cells From Hiding in Bones

Scientists at the Duke Cancer Institute have identified a molecular key that breast cancer cells use to invade bone marrow in mice, where they may be protected from chemotherapy or hormonal therapies that could otherwise eradicate them. Through years of experiments in mice, the scientists have...

Kauff Appointed Director Of Clinical Cancer Genetics

Noah D. Kauff, MD, recently joined Duke University Health System and Duke University School of Medicine as the director of Clinical Cancer Genetics for the Duke Cancer Institute. In his newly appointed position, Kauff will provide leadership, strategy and oversight for Clinical Cancer Genetics and...

May Newsmakers

Read here for a sample of some of the DCI physicians, physician-scientists and researchers whose work was featured in the media and academic journals this month. This list features the Preston Robert Tisch Brain Tumor Center, and also includes Yousuf Zafar, MD and many more.

Bake Sale To Benefit Komen Race For The Cure

Led by DCI patient navigator Xiomara Boyce, team Renacer will host a bake sale on May 26 to benefit the June 11 Komen Triangle Race for The Cure. The bake sale will take place from 8 a.m. to 2 p.m. at Hock Plaza on Erwin Road. The sale will feature Latin-inspired pastries.

Patients Sign On To Race For The Cure

Duke Cancer Institute teamed with Komen North Carolina Triangle To The Coast on Wednesday, May 4, to host a registration kick-off party in which patients were invited to join Team Duke Cancer Institute. The event, held on 0 Level and Level 3 of Duke Cancer Center, provided an opportunity for...

Duke’s Poliovirus Therapy Wins “Breakthrough” Status

The recombinant poliovirus therapy developed at the Preston Robert Tisch Brain Tumor Center at Duke Health has been granted “breakthrough therapy designation” from the U.S. Food and Drug Administration. The designation will expedite research into the poliovirus therapy, but it does not mean the...

Tune To CBS This Sunday Evening

As reported Thursday night, May 12, on CBS Evening News with Scott Pelley, 60 Minutes will update viewers on new developments in Duke's poliovirus therapy for glioblastoma, including the news that the research was granted “breakthrough” status by the FDA to speed development.